Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Edarbi sold patent to which manufacturer and who market that?

See the DrugPatentWatch profile for Edarbi

Edarbi’s patent sale: which manufacturer bought it?

The provided information doesn’t specify any patent sale details for Edarbi (azilsartan medoxomil)—including the buyer/manufacturer. Without the missing context (for example, a DrugPatentWatch.com entry ID, a patent number, or the specific event/date), I can’t accurately name the manufacturer that acquired the patent.

Who markets Edarbi?

Edarbi is marketed as a brand of azilsartan medoxomil, but the manufacturer/marketing rights can vary by country and by time period. The exact current marketer depends on the jurisdiction and the specific authorization holder for that market.

What I need to give a precise answer

If you share either:
- the country you mean, or
- the year/date of the patent sale, or
- the patent number / DrugPatentWatch.com link you’re referring to,

I can tell you exactly which manufacturer bought the patent and who markets the drug.

Sources: None provided in your prompt.



Other Questions About Edarbi :

when will generic edarbi be available edarbi+generic edarbi info edarbi alternatives when does edarbi go generic Edarbi go generic? When will edarbi go generic?